secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viatris Inc (VTRS)
CIK:        0001792044
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001792044-26-000025
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viatris Q1 revenues $3.5B (+8% YoY), adj. EBITDA $1.0B, reaffirms FY guidance
-----------------------------------------------------------------------------

- Total revenues $3.5B, up 8% reported and 3% operational vs Q1 2025.
- US GAAP net earnings $176M; Adjusted EBITDA $1.0B, +10% operationally.
- Reaffirms 2026 financial guidance; expects >$2.5B cash available for deployment.
- Launched Effexor for generalized anxiety disorder in Japan; pipeline milestones progressing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792044/000179204426000025/0001792044-26-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792044/000179204426000025/vtrs-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001792044-26-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer